{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:24:35Z","timestamp":1793831075813,"version":"4.6.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41409-020-01092-x","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T19:02:52Z","timestamp":1603738972000},"page":"818-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching"],"prefix":"10.1038","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2994-9055","authenticated-orcid":false,"given":"Garc\u00eda-Cadenas","family":"Irene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esquirol","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosch-Vilaseca","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-6390","authenticated-orcid":false,"given":"Awol","family":"Rahinatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-0195","authenticated-orcid":false,"given":"Novelli","family":"Silvana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saavedra","family":"Silvana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrido","family":"Ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00f3pez","family":"Jordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caballero Ana","family":"Carolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Granell","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moreno","family":"Carolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briones","family":"Javier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-0356","authenticated-orcid":false,"given":"Sierra","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-4042","authenticated-orcid":false,"given":"Martino","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/tid.12003","volume":"15","author":"SH Kim","year":"2013","unstructured":"Kim SH, Kee SY, Lee DG, Choi SM, Park SH, Kwon JC, et al. Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs myeloablative conditioning regimens. Transpl Infect Dis. 2013;15:49\u201359.","journal-title":"Transpl Infect Dis"},{"key":"1092_CR2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.bmt.1704636","volume":"34","author":"JH Yoo","year":"2004","unstructured":"Yoo JH, Lee DG, Choi SM, Choi JH, Park YH, Kim YJ, et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transpl. 2004;34:497\u2013504.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/320871","volume":"33","author":"E Ninin","year":"2001","unstructured":"Ninin E, Milpied N, Moreau P, Andre-Richet B, Morineau N, Mahe B, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis. 2001;33:41\u201347.","journal-title":"Clin Infect Dis"},{"key":"1092_CR4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bmt.1704338","volume":"33","author":"AE Mitchell","year":"2004","unstructured":"Mitchell AE, Derrington P, Turner P, Hunt LP, Oakhill A, Marks DI. Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome. Bone Marrow Transpl. 2004;33:303\u201310.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001432-200208000-00001","volume":"15","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Marr KA. Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture? Curr Opin Infect Dis. 2002;15:347\u201353.","journal-title":"Curr Opin Infect Dis"},{"key":"1092_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0891-5520(05)70157-4","volume":"15","author":"HL Leather","year":"2001","unstructured":"Leather HL, Wingard JR. Infections following hematopoietic stem cell transplantation. Infect Dis Clin North Am. 2001;15:483\u2013520.","journal-title":"Infect Dis Clin North Am"},{"key":"1092_CR7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bmt.1703643","volume":"30","author":"MG van Kraaij","year":"2002","unstructured":"van Kraaij MG, Verdonck LF, Rozenberg-Arska M, Dekker AW. Early infections in adults undergoing matched related and matched unrelated\/mismatched donor stem cell transplantation: a comparison of incidence. Bone Marrow Transpl. 2002;30:303\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1365-2141.1999.01229.x","volume":"104","author":"EC Williamson","year":"1999","unstructured":"Williamson EC, Millar MR, Steward CG, Cornish JM, Foot AB, Oakhill A, et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol. 1999;104:560\u20138.","journal-title":"Br J Haematol"},{"key":"1092_CR9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","volume":"93","author":"TN Small","year":"1999","unstructured":"Small TN, Papadopoulos EB, Boulad F, Black P, CastroMalaspina H, Childs BH, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999;93:467\u201380.","journal-title":"Blood"},{"key":"1092_CR10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/sj.bmt.1705856","volume":"40","author":"A Bjorklund","year":"2007","unstructured":"Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J, et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;40:1055\u201362. Epub 2007 Sep 24","journal-title":"Bone Marrow Transplant."},{"key":"1092_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s15010-017-1016-1","volume":"45","author":"E Atilla","year":"2017","unstructured":"Atilla E, Atilla PA, Bozda\u011f SC, Demirer T. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection. 2017;45:403\u201311.","journal-title":"Infection."},{"key":"1092_CR12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbmt.2015.09.002","volume":"22","author":"A Bashey","year":"2016","unstructured":"Bashey A, Zhang X, Jackson K, Brown S, Ridgeway M, Solh M, et al. Comparison of outcomes of hematopoietic cell transplants from T-replete haploidentical donors using post-transplantation cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 allelematched unrelated donors and hla-identical sibling donors: a multivariable analysis including disease risk index. Biol Blood Marrow Transpl. 2016;22:125\u201333.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR14","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.3324\/haematol.2015.140509","volume":"101","author":"Y Sun","year":"2016","unstructured":"Sun Y, Beohou E, Labopin M, Volin L, Milpied N, Yakoub-Agha I, et al. Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT data base. Haematologica. 2016;101:e352\u20134.","journal-title":"Haematologica."},{"key":"1092_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00277-019-03870-0","volume":"99","author":"A Esquirol","year":"2020","unstructured":"Esquirol A, Querol S, Garcia-Cadenas I, Novelli S, Garrido A, Saavedra S, et al. When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine). Ann Hematol. 2020 Jan;99:157\u201365.","journal-title":"Ann Hematol"},{"key":"1092_CR16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","volume":"11","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, Afanasyev B, Cornelissen JJ, Elmaagacli A, et al. Posttransplant cyclophosphamide for GVHD prophylaxis in HLA matched sibling or matched-unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. J Hematol Oncol. 2018;11:40.","journal-title":"J Hematol Oncol"},{"key":"1092_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41409-018-0367-2","volume":"54","author":"MV Shah","year":"2019","unstructured":"Shah MV, Saliba RM, Rondon G, Chen J, Soebbing D, Rus I, et al. Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for olderpatientsreceiving 10\/10 HLA-matched unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transpl. 2019;54:601\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ejh.13230","volume":"102","author":"S Prem","year":"2019","unstructured":"Prem S, Atenafu EG, Al-Shaibani Z, Loach D, Law A, Lam W, et al. Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral bloodstem cell transplants. Eur J Haematol. 2019;102:486\u201393.","journal-title":"Eur J Haematol"},{"key":"1092_CR19","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Cadenas I, Awol R, Esquirol A, Saavedra S, Bosch-Vilaseca A, Novelli S, et al. Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature. Bone Marrow Transpl. 2020;55:1041\u20139.","DOI":"10.1038\/s41409-019-0771-2"},{"key":"1092_CR20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1182\/blood-2005-11-4503","volume":"108","author":"R Martino","year":"2006","unstructured":"Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J, et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplasticsyndromes. Myelodysplastic Syndrome subcommittee of the Chronic Leukemia Working Party of the European Blood and Marrow Transplantation Group. Blood. 2006;108:836\u201346.","journal-title":"Blood."},{"key":"1092_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bmt.2014.220","volume":"50","author":"R Parody","year":"2015","unstructured":"Parody R, Lopez-Corral L, Godino OL, Cadenas IG, Martinez AP, Vazquez L, et al. GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning alloSCT. Bone Marrow Transpl. 2015;50:121\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR22","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/bmt.2009.362","volume":"45","author":"JL Pi\u00f1ana","year":"2010","unstructured":"Pi\u00f1ana JL, Valc\u00e1rcel D, Fern\u00e1ndez-Avil\u00e9s F, Martino R, Rovira M, Barba P, et al. MTX or mycophenolatemofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings. Bone Marrow Transpl. 2010;45:1449\u201356.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR23","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1200\/JCO.2013.54.0625","volume":"32","author":"CG Kanakry","year":"2014","unstructured":"Kanakry CG, O\u2019Donnell PV, Furlong T, de Lima MJ, Wei W, Medeot M, et al. Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablativebusulfan and fludarabine conditioning. J Clin Oncol. 2014;32:3497\u2013505.","journal-title":"J Clin Oncol"},{"key":"1092_CR24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/bmt.2009.180","volume":"45","author":"JL Pi\u00f1ana","year":"2010","unstructured":"Pi\u00f1ana JL, Martino R, Barba P, Margall N, Roig MC, Valc\u00e1rcel D, et al. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience. Bone Marrow Transpl. 2010;45:534\u201342.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR25","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. Consensus conference on acute GVHD grading. Bone Marrow Transpl Bone Marrow Transpl. 1995;15:825\u20138.","journal-title":"Bone Marrow Transpl Bone Marrow Transpl"},{"key":"1092_CR26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","volume":"21","author":"StephanieJ Lee","year":"2015","unstructured":"Lee StephanieJ, Wolff D, Kitko C, Koreth J, Inamoto Y, et al. Measuring therapeutic response in chronic graft-versus-host disease. national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. the 2014 response Criteria Working Group. Biol Blood Marrow Transpl. 2015;21:984\u201399.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bbmt.2007.08.047","volume":"13","author":"E Copelan","year":"2007","unstructured":"Copelan E, Casper JT, Carter SL, van Burik JAH, Hurd D, Mendizabal AM, et al. A scheme for defining cause of death and its application in the T cell depletion trial. Biol Blood Marrow Transpl. 2007;13:1469\u201376.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the sub-distribution of acompeting risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"1092_CR29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","volume":"11","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, Afanasyev B, Cornelissen JJ, Elmaagacli A, et al. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. A J Hematol Oncol. 2018;11:40.","journal-title":"A J Hematol Oncol"},{"key":"1092_CR30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41409-019-0475-7","volume":"54","author":"A Fayard","year":"2019","unstructured":"Fayard A, Daguenet E, Blaise D, Chevallier P, Labussi\u00e8re H, Berceanu A, et al. Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transpl. 2019;54:1586\u201394.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR31","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/bjh.16189","volume":"187","author":"R Mohty","year":"2019","unstructured":"Mohty R, Brissot E, Battipaglia G, Ruggeri A, Dulery R, et al. Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation. Br J Haematol. 2019;187:e64\u2013e68.","journal-title":"Br J Haematol"},{"key":"1092_CR32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/tid.12365","volume":"17","author":"R Crocchiolo","year":"2015","unstructured":"Crocchiolo R, Bramanti S, Vai A, Sarina B, Mineri R, Casari E, et al. Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis. Transpl Infect Dis. 2015;17:242\u20139.","journal-title":"Transpl Infect Dis"},{"key":"1092_CR33","doi-asserted-by":"crossref","first-page":"e1918668","DOI":"10.1001\/jamanetworkopen.2019.18668","volume":"3","author":"CE Dandoy","year":"2020","unstructured":"Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, et al. Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant. JAMA Netw Open. 2020;3:e1918668. 3","journal-title":"JAMA Netw Open"},{"key":"1092_CR34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/bmt.2017.14","volume":"52","author":"CE Dandoy","year":"2017","unstructured":"Dandoy CE, Ardura MI, Papanicolaou GA, Auletta JJ. Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis. Bone Marrow Transpl. 2017;52:1091\u2013106.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2017.08.024","volume":"24","author":"M Mikulska","year":"2018","unstructured":"Mikulska M, Raiola AM, Galaverna F, Balletto E, Borghesi ML, Varaldo R, et al. Preengraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of T cell-replete transplantation from a haploidentical donor. Biol Blood Marrow Transpl. 2018;24:109\u201318.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/tid.12361","volume":"17","author":"R Martino","year":"2015","unstructured":"Martino R, Bautista G, Parody R, Garc\u00eda I, Esquirol A, Rovira M, et al. Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Espa\u00f1ol de Trasplante Hematopoy\u00e9tico (GETH). Transpl Infect Dis. 2015;17:221\u201333.","journal-title":"Transpl Infect Dis"},{"key":"1092_CR37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2006.03.007","volume":"12","author":"R Parody","year":"2006","unstructured":"Parody R, Martino R, Rovira M, Vazquez L, V\u00e1zquez MJ, de la C\u00e1mara R, et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transpl. 2006;12:734\u201348.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-3062.2005.00088.x","volume":"7","author":"NG Almyroudis","year":"2005","unstructured":"Almyroudis NG, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small T, et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005;7:11\u20137.","journal-title":"Transpl Infect Dis"},{"key":"1092_CR39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/JBM.S201073","volume":"10","author":"J Chang","year":"2019","unstructured":"Chang J, Hsiao M, Blodget E, Akhtari MJ. Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation. Blood Med. 2019;10:135\u201343. 15","journal-title":"Blood Med"},{"key":"1092_CR40","first-page":"30045","volume":"S1083-8791","author":"C Oltolini","year":"2020","unstructured":"Oltolini C, Greco R, Galli L, Clerici D, Lorentino F, Xue E, et al. Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA matching. Biol Blood Marrow Transpl. 2020;S1083-8791:30045\u20138. 28","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbmt.2016.11.005","volume":"23","author":"F Patriarca","year":"2017","unstructured":"Patriarca F, Cigana C, Massimo D, Lazzarotto D, Geromin A, Isola M, et al. Risk factors and outcomes of infections by multidrug-resistant gram-negative bacteria in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2017;23:333\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41409-019-0701-3","volume":"55","author":"P Puerta-Alcalde","year":"2020","unstructured":"Puerta-Alcalde P, Cardozo C, Marco F, Su\u00e1rez-Lled\u00f3 M, Moreno E, Morata L, et al. Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes. Bone Marrow Transpl. 2020;55:603\u201312.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbmt.2016.02.009","volume":"22","author":"J Bilinski","year":"2016","unstructured":"Bilinski J, Robak K, Peric Z, Marchel H, Karakulska-Prystupiuk E, Halaburda K. Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective, single-center study. Biol Blood Marrow Transpl. 2016;22:1087\u201393.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbmt.2008.10.024","volume":"15","author":"M Mikulska","year":"2009","unstructured":"Mikulska M, Bono V, Raiola A, Bruno B, Gualandi F, Occhini D, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transpl. 2009;15:47\u201353.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR45","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/bmt.2017.200","volume":"52","author":"C Liu","year":"2017","unstructured":"Liu C, Frank DN, Horch M, Chau S, Ir D, Horch EA, et al. Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors. Bone Marrow Transpl. 2017;52:1643\u201350.","journal-title":"Bone Marrow Transpl"},{"key":"1092_CR46","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.3389\/fimmu.2018.03179","volume":"9","author":"N K\u00f6hler","year":"2019","unstructured":"K\u00f6hler N, Zeiser R. Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD. Front Immunol. 2019;9:3179. 17.","journal-title":"Front Immunol"},{"key":"1092_CR47","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bbmt.2012.02.010","volume":"18","author":"L Willems","year":"2012","unstructured":"Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transpl. 2012;18:1295\u2013301.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR48","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/cid\/cir1035","volume":"54","author":"CD Alonso","year":"2012","unstructured":"Alonso CD, Treadway SB, Hanna DB, Huff CA, Neofytos D, Carroll KC, et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2012;54:1053\u201363.","journal-title":"Clin Infect Dis"},{"key":"1092_CR49","first-page":"1","volume":"5","author":"M Santiago","year":"2019","unstructured":"Santiago M, Eysenbach L, Allegretti J, Aroniadis O, Brandt LJ, Fischer M, et al. Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study. Microbiol. 2019;5:1\u201318. 17","journal-title":"Microbiol"},{"key":"1092_CR50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/QCO.0b013e3283630c4c","volume":"26","author":"CD Alonso","year":"2013","unstructured":"Alonso CD, Marr KA. Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis. Curr Opin Infect Dis. 2013;26:326\u201331.","journal-title":"Curr Opin Infect Dis"},{"key":"1092_CR51","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-6: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091\u2013100. 15","journal-title":"Clin Infect Dis"},{"key":"1092_CR52","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jmii.2015.01.002","volume":"49","author":"YC Liu","year":"2016","unstructured":"Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, et al. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. J Microbiol Immunol Infect. 2016;49:567\u201374.","journal-title":"J Microbiol Immunol Infect"},{"key":"1092_CR53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tid.12455","volume":"17","author":"A Ruggeri","year":"2015","unstructured":"Ruggeri A, Roth-Guepin G, Battipaglia G, Mamez AC, Malard F, Gomez A, et al. Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients. Transpl Infect Dis. 2015;17:822\u201330.","journal-title":"Transpl Infect Dis"},{"key":"1092_CR54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","volume":"25","author":"OR Copelan","year":"2019","unstructured":"Copelan OR, Sanikommu SR, Trivedi JS, Butler C, Ai J, Ragon BK, et al. Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation. Biol Blood Marrow Transpl. 2019;25:785\u201390.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR55","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.bbmt.2013.07.013","volume":"19","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA, Kasamon YL, Bola\u00f1os-Meade J, Borrello IM, Brodsky RA, Fuchs EJ, et al. Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biol Blood Marrow Transpl. 2013;19:1514\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR56","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbmt.2013.11.028","volume":"20","author":"YJ Chang","year":"2014","unstructured":"Chang YJ, Zhao XY, Huang XJ. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20:440.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR57","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2019.12.724","volume":"26","author":"T Marinelli","year":"2020","unstructured":"Marinelli T, Wee LYA, Rowe E, Chhetri R, Friel O, Higgins G, et al. Respiratory viruses cause late morbidity in recipients of hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2020;26:782\u20138.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1092_CR58","doi-asserted-by":"crossref","first-page":"e12926","DOI":"10.1111\/tid.12926","volume":"20","author":"JL Pi\u00f1ana","year":"2018","unstructured":"Pi\u00f1ana JL, G\u00f3mez MD, P\u00e9rez A, Madrid S, Balaguer-Rosell\u00f3 A, Gim\u00e9nez E, et al. Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: risk factors and mortality from pulmonary virus-bacterial mixed infections. Transpl Infect Dis. 2018;20:e12926.","journal-title":"Transpl Infect Dis"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-020-01092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-020-01092-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-020-01092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:30:23Z","timestamp":1744151423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-020-01092-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1038\/s41409-020-01092-x","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}